线粒体健康指数与双相障碍血浆游离线粒体DNA相关
研究纳入14例双相障碍I型患者和16名年龄性别匹配的非精神科对照,检测外周血单核细胞线粒体酶活性、线粒体DNA拷贝数及血浆游离线粒体DNA。调整年龄、性别、BMI和吸烟状态后,患者线粒体健康指数(MHI)更低、游离线粒体DNA更高,且MHI与游离线粒体DNA负相关,低MHI与更长病程、更差功能状态和更高抑郁症状相关。
要点
- 双相障碍患者MHI低于对照,血浆游离线粒体DNA水平更高。
- MHI与游离线粒体DNA负相关,并与线粒体质量控制蛋白相关。
- 低MHI和髙游离线粒体DNA与更长病程、更差功能及更高抑郁症状相关。
核心结论
- 线粒体适应负荷参与双相障碍,线粒体功能可能是连接细胞韧性受损与应激易感的生物学交叉点。
- MHI与游离线粒体DNA可能成为解释双相障碍疾病进展和治疗靶点的预测标志物。
研究设计与样本
- 研究纳入14例双相障碍I型患者和16名年龄性别匹配的非精神科对照。
- 检测外周血单核细胞的柠檬酸合酶及复合体I、II、IV酶活性和线粒体DNA拷贝数,血浆游离线粒体DNA用qPCR评估,线粒体质量控制蛋白用western blotting评估。
- 分析时调整了年龄、性别、体重指数和吸烟状态等混杂变量。
主要发现
- 调整混杂变量后,双相障碍患者MHI低于非精神科对照,且游离线粒体DNA水平更高并与MHI负相关。
- MHI与Fis-1负相关、与Opa-1和LC3正相关;游离线粒体DNA与Fis-1正相关、与Opa-1和LC3负相关。
- 疾病严重程度与MHI呈负相关,病程更长、功能状态更差和抑郁症状更高的受试者MHI更低、游离线粒体DNA更高。
关键数值与推荐
- 双相障碍患者MHI低于非精神科对照,游离线粒体DNA水平高于对照。
- 游离线粒体DNA与MHI呈负相关。
- MHI与Fis-1负相关、与Opa-1和LC3正相关;游离线粒体DNA与Fis-1正相关、与Opa-1和LC3负相关。
- 疾病严重程度与MHI呈负相关。
临床怎么用
- 线粒体健康指数和血浆游离线粒体DNA可作为评估双相障碍疾病进展和预后的潜在生物标志物。
- 线粒体功能及其调控可能为双相障碍的旧靶点和新靶点治疗提供指导。
局限性
- 样本量较小,仅纳入14例双相障碍I型患者和16名对照。
- 研究为横断面设计,无法推断线粒体功能与临床结局的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although mitochondrial dysfunction is known to play an essential role in the pathophysiology of bipolar disorder (BD), there is a glaring gap in our understanding of how mitochondrial dysfunction can modulate clinical phenotypes. An emerging paradigm suggests mitochondria play an important non-energetic role in adaptation to stress, impacting cellular resilience and acting as a source of systemic allostatic load. Known as mitochondrial allostatic load, this (phenomenon) occurs when mitochondria are unable to recalibrate and maintain cell homeostasis. This study aimed to evaluate the composite mitochondrial health index (MHI) in BD subjects and non-psychiatry controls. We will also explore whether lower MIH will be related to higher cell-free mtDNA (ccf-mtDNA) levels and poor clinical outcomes. In this study, 14 BD-I patients and 16 age- and sex-matched non-psychiatry controls were enrolled. Peripheral blood mononuclear cells (PBMCs) were used to measure the enzymatic activities of citrate synthase and complexes I, II, and IV and mtDNA copy number. Ccf-mtDNA was evaluated by qPCR in plasma. Mitochondrial quality control (MQC) proteins were evaluated by western blotting. After adjusting for confounding variables, such as age, sex, body mass index (BMI), and smoking status, patients with BD presented lower MHI compared to non-psychiatry controls, as well as higher ccf-mtDNA levels that negatively correlated with MHI. Because the MQC network is essential to maintain mitochondrial health, MHI and ccf-mtDNA were also examined in relation to several MQC-related proteins, such as Fis-1, Opa-1, and LC3. Our results showed that MHI correlated negatively with Fis-1 and positively with Opa-1 and LC3. Accordingly, ccf-mtDNA had a positive correlation with Fis-1 and a negative correlation with Opa-1 and LC3. Furthermore, we found a noteworthy inverse correlation between illness severity and MHI, with lower MHI and higher ccf-mtDNA levels in subjects with a longer illness duration, worse functional status, and higher depressive symptoms. Our findings indicate that mitochondrial allostatic load contributes to BD, suggesting mitochondria represent a potential biological intersection point that could contribute to impaired cellular resilience and increased vulnerability to stress and mood episodes. Ultimately, by linking mitochondrial dysfunction to disease progression and poor outcomes, we might be able to build a predictive marker that explains how mitochondrial function and its regulation contribute to BD development and that may eventually serve as a treatment guide for both old and new therapeutic targets.
引用
- Cordeiro RC, Lima CNC, Fries GR, et al. Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder. Mol Psychiatry. 2023. PMID: 37723283. doi:10.1038/s41380-023-02249-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。